Background and purpose. Two new technologies hold the promise to revolutionize cardiac safety and drug development: in vitro experiments on human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) and in silico human adult ventricular cardiomyocyte (hAdultV-CM) models. Their combination was recently proposed as a potential replacement for the present hERG-based QT study in safety pharmacology assessment. Here, we systematically compare in silico the effects of selective ionic current block on hiPSC-CM and hAdultV-CM action potentials (APs), to identify similarities/differences and to illustrate the potential of computational models as supportive tools for evaluating new in vitro technologies. Experimental approach. In silico A...
Human-induced pluripotent stem cell (hiPSC)-derived cardiomyocytes are likely to revolutionize elect...
Human-induced pluripotent stem cell (hiPSC)-derived cardiomyocytes are likely to revolutionize elect...
Improvements in human stem cell-derived cardiomyocyte (hSC-CM) technology have promoted their use fo...
Background and Purpose Two new technologies are likely to revolutionize cardiac safety and drug deve...
Background and Purpose Two new technologies are likely to revolutionize cardiac safety and drug deve...
Two new technologies are likely to revolutionize cardiac safety and drug development: in vitro exper...
none4siThe clear importance of human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs...
Human induced pluripotent stem cells (hiPSCs) represent nowadays a valuable in-vitro model to study ...
Human induced pluripotent stem cells (hiPSCs) represent nowadays a valuable in-vitro model to study ...
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are characterized by an extre...
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are characterized by an extre...
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are characterized by an extre...
Abstract Background: Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) have eme...
Background: Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) have emerged as a...
Human induced pluripotent stem cell cardiomyocytes (hiPSC-CMs) offer a new in vitro model to study c...
Human-induced pluripotent stem cell (hiPSC)-derived cardiomyocytes are likely to revolutionize elect...
Human-induced pluripotent stem cell (hiPSC)-derived cardiomyocytes are likely to revolutionize elect...
Improvements in human stem cell-derived cardiomyocyte (hSC-CM) technology have promoted their use fo...
Background and Purpose Two new technologies are likely to revolutionize cardiac safety and drug deve...
Background and Purpose Two new technologies are likely to revolutionize cardiac safety and drug deve...
Two new technologies are likely to revolutionize cardiac safety and drug development: in vitro exper...
none4siThe clear importance of human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs...
Human induced pluripotent stem cells (hiPSCs) represent nowadays a valuable in-vitro model to study ...
Human induced pluripotent stem cells (hiPSCs) represent nowadays a valuable in-vitro model to study ...
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are characterized by an extre...
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are characterized by an extre...
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are characterized by an extre...
Abstract Background: Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) have eme...
Background: Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) have emerged as a...
Human induced pluripotent stem cell cardiomyocytes (hiPSC-CMs) offer a new in vitro model to study c...
Human-induced pluripotent stem cell (hiPSC)-derived cardiomyocytes are likely to revolutionize elect...
Human-induced pluripotent stem cell (hiPSC)-derived cardiomyocytes are likely to revolutionize elect...
Improvements in human stem cell-derived cardiomyocyte (hSC-CM) technology have promoted their use fo...